New Medicare Ruling Speeds Approval of Innovative Healthcare Technology
Share Article
A new Medicare approval procedure will ease seniors’ access to potentially lifesaving technology. Ensurem CEO Dave Rich says the new ruling may lead to devices that would otherwise not have been developed.
Before the ruling, FDA approval of a new medical device was followed by an often lengthy and expensive second approval process for Medicare coverage.
A breakthrough device . is something that provides for more effective treatment of a life-threatening or irreversibly debilitating disease. For some patients, this accelerated access could be a life-saver. CLEARWATER, Fla. (PRWEB) March 16, 2021 As of March 15, a new Medicare coverage pathway, Medicare Coverage of Innovative Technology (MCIT), will provide national Medicare coverage for breakthrough devices as soon as the Food and Drug Administration approves them.(1) “A br
Investegate |Renalytix AI PLC Announcements | Renalytix AI PLC: Update on Finalization of MCIT Rule investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
TRADING UPDATES: Arix backs buyback; 88 Energy notes share price surge
Mon, 15th Mar 2021 21:44
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Arix Bioscience PLC - focused on investing in biotech companies - Says board approves buyback of up to GBP25 million worth of shares. The share buyback programme is consistent with Arix s strategy of creating and delivering value for all stakeholders and follows shareholder consultation as part of the company s stated commitment to keep use of cash under review, following the trade sale of VelosBio, Arix says.
Renalytix AI notes delay of implementation date for US medicare coverage | 15 March 2021 stockmarketwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockmarketwire.com Daily Mail and Mail on Sunday newspapers.
POLITICO
Get the Prescription Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by Coalition for Affordable Prescription Drugs
With Brianna Ehley and Emily Martin.
On Tap Novavax touts the effectiveness of its Covid-19 vaccine. FDA scrutinizes its accelerated drug approval program.
It’s Tuesday, welcome back to Prescription Pulse. Turns out Transportation Secretary Pete Buttigieg is competing with the rest of us for D.C.’s scarce bicycle stock. As always, send tips to Sarah Owermohle ([email protected] or @owermohle) and David Lim ([email protected] or @davidalim).